Recall of Children’s Panadol products
CONSUMERS and health professionals are advised that GlaxoSmithKline Consumer Healthcare Australia, in consultation with the TGA, is in the process of recalling three batches of Children's Panadol 5-12 years suspension, supplied in 200m bottles.
It has been identified that an ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres.
The quantity of these particles would be small and they may not be visible in the product.
If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.
The affected batch numbers are:136418 (strawberry flavour), 136444 (strawberry flavour) and 136443 (orange flavour).
The expiry date for each of the recalled products is February 2018.
The batch number and expiry date are located at the bottom of the bottle label and embossed on the base of the outer box.
No other batches, bottle sizes or products are affected by this recall.
If you have a bottle of Children's Panadol 5-12 years suspension, check the bottle label and/or the base of the outer box to see if it is from batch numbers 136418 (strawberry flavour), 136444 (strawberry flavour) or 136443 (orange flavour).
If you have a bottle from one of the affected batches, do not use it.
Return it to the place of purchase for a refund.
If you have any questions or concerns about this issue, speak to your health professional, or call GlaxoSmithKline Consumer Healthcare Australia on 1800 028 533.